Skip to main content
  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Meeting Abstracts
    • Cancer Immunology Essentials
    • Collections
      • COVID-19 & Cancer Resource Center
      • Toolbox: Coding and Computation
      • Toolbox: Signatures and Cells
      • "Best of" Collection
      • Editors' Picks
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Cancer Immunology Research
Cancer Immunology Research
  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Meeting Abstracts
    • Cancer Immunology Essentials
    • Collections
      • COVID-19 & Cancer Resource Center
      • Toolbox: Coding and Computation
      • Toolbox: Signatures and Cells
      • "Best of" Collection
      • Editors' Picks
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

Research Articles

A Four-Factor Immunoscore System That Predicts Clinical Outcome for Stage II/III Gastric Cancer

Ti Wen, Zhenning Wang, Yi Li, Zhi Li, Xiaofang Che, Yibo Fan, Shuo Wang, Jinglei Qu, Xianghong Yang, Kezuo Hou, Wenyang Zhou, Ling Xu, Ce Li, Jin Wang, Jing Liu, Liqun Chen, Jingdong Zhang, Xiujuan Qu and Yunpeng Liu
Ti Wen
1Department of Medical Oncology, Key Laboratory of Anticancer Drugs and Biotherapy of Liaoning Province, The First Hospital of China Medical University, Heping District, Shenyang, China.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Zhenning Wang
2Department of Surgical Oncology and General Surgery, The First Hospital of China Medical University, Heping District, Shenyang, China.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yi Li
3Department of Pathology, Cancer Hospital of Liaoning Province, Dadong District, Shenyang, China.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Zhi Li
1Department of Medical Oncology, Key Laboratory of Anticancer Drugs and Biotherapy of Liaoning Province, The First Hospital of China Medical University, Heping District, Shenyang, China.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Xiaofang Che
1Department of Medical Oncology, Key Laboratory of Anticancer Drugs and Biotherapy of Liaoning Province, The First Hospital of China Medical University, Heping District, Shenyang, China.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yibo Fan
1Department of Medical Oncology, Key Laboratory of Anticancer Drugs and Biotherapy of Liaoning Province, The First Hospital of China Medical University, Heping District, Shenyang, China.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shuo Wang
1Department of Medical Oncology, Key Laboratory of Anticancer Drugs and Biotherapy of Liaoning Province, The First Hospital of China Medical University, Heping District, Shenyang, China.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jinglei Qu
1Department of Medical Oncology, Key Laboratory of Anticancer Drugs and Biotherapy of Liaoning Province, The First Hospital of China Medical University, Heping District, Shenyang, China.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Xianghong Yang
4Department of Pathology, Shengjing Hospital of China Medical University, Heping District, Shenyang, China.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kezuo Hou
1Department of Medical Oncology, Key Laboratory of Anticancer Drugs and Biotherapy of Liaoning Province, The First Hospital of China Medical University, Heping District, Shenyang, China.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Wenyang Zhou
4Department of Pathology, Shengjing Hospital of China Medical University, Heping District, Shenyang, China.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ling Xu
1Department of Medical Oncology, Key Laboratory of Anticancer Drugs and Biotherapy of Liaoning Province, The First Hospital of China Medical University, Heping District, Shenyang, China.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ce Li
1Department of Medical Oncology, Key Laboratory of Anticancer Drugs and Biotherapy of Liaoning Province, The First Hospital of China Medical University, Heping District, Shenyang, China.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jin Wang
1Department of Medical Oncology, Key Laboratory of Anticancer Drugs and Biotherapy of Liaoning Province, The First Hospital of China Medical University, Heping District, Shenyang, China.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jing Liu
1Department of Medical Oncology, Key Laboratory of Anticancer Drugs and Biotherapy of Liaoning Province, The First Hospital of China Medical University, Heping District, Shenyang, China.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Liqun Chen
3Department of Pathology, Cancer Hospital of Liaoning Province, Dadong District, Shenyang, China.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jingdong Zhang
5Department of Medical Oncology, Cancer Hospital of Liaoning Province, Dadong District, Shenyang, China.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Xiujuan Qu
1Department of Medical Oncology, Key Laboratory of Anticancer Drugs and Biotherapy of Liaoning Province, The First Hospital of China Medical University, Heping District, Shenyang, China.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: cmuliuyunpeng@hotmail.com xiujuanqu@yahoo.com
Yunpeng Liu
1Department of Medical Oncology, Key Laboratory of Anticancer Drugs and Biotherapy of Liaoning Province, The First Hospital of China Medical University, Heping District, Shenyang, China.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: cmuliuyunpeng@hotmail.com xiujuanqu@yahoo.com
DOI: 10.1158/2326-6066.CIR-16-0381 Published July 2017
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Online Impact

Statistics from Altmetric.com

ARTICLE USAGE

ARTICLE USAGE: June 2017 to February 2021

AbstractFull-text HTMLPDF
Total306530151675

Cited By

Article Information

Volume 5, Issue 7, pp. 524-534

DOI 
https://doi.org/10.1158/2326-6066.CIR-16-0381
PubMed 
28619967

Published By 
American Association for Cancer Research
Print ISSN 
2326-6066
Online ISSN 
2326-6074
History 
  • Received December 20, 2016
  • Revision received April 20, 2017
  • Accepted May 31, 2017
  • Published first June 15, 2017.

Article Versions

  • Previous version (June 15, 2017 - 05:43).
  • You are viewing the most recent version of this article.
Copyright & Usage 
©2017 American Association for Cancer Research.

Author Information

  1. Ti Wen1,
  2. Zhenning Wang2,
  3. Yi Li3,
  4. Zhi Li1,
  5. Xiaofang Che1,
  6. Yibo Fan1,
  7. Shuo Wang1,
  8. Jinglei Qu1,
  9. Xianghong Yang4,
  10. Kezuo Hou1,
  11. Wenyang Zhou4,
  12. Ling Xu1,
  13. Ce Li1,
  14. Jin Wang1,
  15. Jing Liu1,
  16. Liqun Chen3,
  17. Jingdong Zhang5,
  18. Xiujuan Qu1,*, and
  19. Yunpeng Liu1,*
  1. 1Department of Medical Oncology, Key Laboratory of Anticancer Drugs and Biotherapy of Liaoning Province, The First Hospital of China Medical University, Heping District, Shenyang, China.
  2. 2Department of Surgical Oncology and General Surgery, The First Hospital of China Medical University, Heping District, Shenyang, China.
  3. 3Department of Pathology, Cancer Hospital of Liaoning Province, Dadong District, Shenyang, China.
  4. 4Department of Pathology, Shengjing Hospital of China Medical University, Heping District, Shenyang, China.
  5. 5Department of Medical Oncology, Cancer Hospital of Liaoning Province, Dadong District, Shenyang, China.
  1. ↵*Corresponding Authors:
    Yunpeng Liu, The First Hospital of China Medical University, No. 155, Nanjing North Street, Heping District, Shenyang 110001, China. Phone: 86-24-83282312; Fax: 86-24-83282312; E-mail: cmuliuyunpeng{at}hotmail.com. Xiujuan Qu, Phone:/Fax: 86-(0)24-83282312; E-mail: xiujuanqu{at}yahoo.com
  1. T. Wen and Z. Wang contributed equally to this article.

View Full Text
PreviousNext
Back to top
Cancer Immunology Research: 5 (7)
July 2017
Volume 5, Issue 7
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Editorial Board (PDF)

Sign up for alerts

View this article with LENS

Open full page PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Cancer Immunology Research article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
A Four-Factor Immunoscore System That Predicts Clinical Outcome for Stage II/III Gastric Cancer
(Your Name) has forwarded a page to you from Cancer Immunology Research
(Your Name) thought you would be interested in this article in Cancer Immunology Research.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
A Four-Factor Immunoscore System That Predicts Clinical Outcome for Stage II/III Gastric Cancer
Ti Wen, Zhenning Wang, Yi Li, Zhi Li, Xiaofang Che, Yibo Fan, Shuo Wang, Jinglei Qu, Xianghong Yang, Kezuo Hou, Wenyang Zhou, Ling Xu, Ce Li, Jin Wang, Jing Liu, Liqun Chen, Jingdong Zhang, Xiujuan Qu and Yunpeng Liu
Cancer Immunol Res July 1 2017 (5) (7) 524-534; DOI: 10.1158/2326-6066.CIR-16-0381

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
A Four-Factor Immunoscore System That Predicts Clinical Outcome for Stage II/III Gastric Cancer
Ti Wen, Zhenning Wang, Yi Li, Zhi Li, Xiaofang Che, Yibo Fan, Shuo Wang, Jinglei Qu, Xianghong Yang, Kezuo Hou, Wenyang Zhou, Ling Xu, Ce Li, Jin Wang, Jing Liu, Liqun Chen, Jingdong Zhang, Xiujuan Qu and Yunpeng Liu
Cancer Immunol Res July 1 2017 (5) (7) 524-534; DOI: 10.1158/2326-6066.CIR-16-0381
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Materials and Methods
    • Results
    • Discussion
    • Disclosure of Potential Conflicts of Interest
    • Authors' Contributions
    • Grant Support
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF
Advertisement

Related Articles

Cited By...

More in this TOC Section

  • Nutlin-3a: An Immune-Checkpoint Activator for NK Cells in Neuroblastoma
  • Therapy to Engage, Expand, and Enable Antitumor Responses
  • Dietary Fructose Promotes Resistance to Cancer Immunotherapy
Show more Research Articles
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook   Twitter   LinkedIn   YouTube   RSS

Articles

  • Online First
  • Current Issue
  • Past Issues
  • Cancer Immunology Essentials

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About Cancer Immunology Research

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Cancer Immunology Research
eISSN: 2326-6074
ISSN: 2326-6066

Advertisement